Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mucin layer of the ocular surface is a composite structure formed by high molecular weight glycoproteins (mucins) secreted by goblet cells and expressed on epithelial membranes (membrane-associated mucins). This layer is essential for tear film stability, lubrication, epithelial protection, debris/pathogen clearance, and minimizing evaporation. It prevents direct pathogenic binding and reduces friction during blinking by making the ocular surface highly hydrophilic and forming a barrier known as the glycocalyx. Major ocular surface mucins include secreted mucins (e.g., MUC5AC) and membrane-associated mucins (e.g., MUC1, MUC4, MUC16). Alteration in the mucin layer composition or structure underlies several ocular surface disorders, principally dry eye disease and infection susceptibility[2][3][7][8].
Drugs targeting mucin function modulate secretion or enhance integrity of the mucin layer (e.g., stimulating goblet cell secretion, supporting mucin glycosylation)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin layer of the ocular surface.